Sancilio Pharmaceuticals

Sancilio Pharmaceuticals is an integrated specialty pharmaceutical company dedicated to developing (and commercializing in the future) its proprietary "Advanced Lipid Technologies (ALT)" platform. In 2012, Sancilio Pharmaceuticals merged and reorganized with Sancilio & Company into a Delaware corporation, and in 2015, it was restructured into a holding company—Sancilio Pharmaceuticals Company, Inc.—with Sancilio & Company, Inc. becoming its wholly owned subsidiary.